These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21063228)

  • 21. Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation.
    Grabmeier-Pfistershammer K; Rieger A; Schröck T; Schlag M
    Wien Klin Wochenschr; 2013 Jul; 125(13-14):402-7. PubMed ID: 23807043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.
    Pillai N; Foster N; Hanifa Y; Ndlovu N; Fielding K; Churchyard G; Chihota V; Grant AD; Vassall A
    PLoS One; 2019; 14(2):e0210622. PubMed ID: 30742623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the cost of medications for ambulatory HIV-infected persons in association with landmark changes in antiretroviral therapy.
    Perdue BE; Weidle PJ; Everson-Mays RE; Bozek PS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):354-60. PubMed ID: 9525437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.
    Hill AM; Gebo K; Hemmett L; Löthgren M; Allegri G; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():169-81. PubMed ID: 21182350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost of HIV disease in Northern Italy: the payer's perspective.
    Rizzardini G; Restelli U; Bonfanti P; Porazzi E; Ricci E; Casartelli L; Foglia E; Carenzi L; Citterio P; Orlando G; Maselli C; Croce D
    J Acquir Immune Defic Syndr; 2011 Jul; 57(3):211-7. PubMed ID: 21546850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inpatient, Outpatient, and Pharmacy Costs in Patients With and Without HIV in the US Veteran's Affairs Administration System.
    Sutton S; Magagnoli J; Cummings T; Hardin J; Edun B
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219855377. PubMed ID: 31213120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost effectiveness of combination antiretroviral therapy for HIV disease.
    Freedberg KA; Losina E; Weinstein MC; Paltiel AD; Cohen CJ; Seage GR; Craven DE; Zhang H; Kimmel AD; Goldie SJ
    N Engl J Med; 2001 Mar; 344(11):824-31. PubMed ID: 11248160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost of HIV treatment in highly active antiretroviral therapy in Japan].
    Kimura H
    Nihon Rinsho; 2002 Apr; 60(4):813-6. PubMed ID: 11968794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France.
    Colin X; Lafuma A; Costagliola D; Lang JM; Guillon P
    Pharmacoeconomics; 2010; 28 Suppl 1():59-68. PubMed ID: 21182344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.
    Bozzette SA; Joyce G; McCaffrey DF; Leibowitz AA; Morton SC; Berry SH; Rastegar A; Timberlake D; Shapiro MF; Goldman DP;
    N Engl J Med; 2001 Mar; 344(11):817-23. PubMed ID: 11248159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consequences of adult HIV infection for outpatient morbidity and treatment costs: a prospective study in a factory clinic in Tanzania.
    Kikumbih SN; Isingo R; Boerma JT
    Health Policy Plan; 1997 Sep; 12(3):234-9. PubMed ID: 10173404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality.
    Seal PS; Jackson DA; Chamot E; Willig JH; Nevin CR; Allison JJ; Raper JL; Kempf MC; Schumacher JE; Saag MS; Mugavero MJ
    J Gen Intern Med; 2011 Jul; 26(7):745-50. PubMed ID: 21465301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
    Krentz HB; Gill MJ
    HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001.
    Rutstein RM; Gebo KA; Siberry GK; Flynn PM; Spector SA; Sharp VL; Fleishman JA
    Med Care; 2005 Sep; 43(9 Suppl):III31-9. PubMed ID: 16116307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric HIV costs across three treatment eras from 1986 to 2007.
    Wilson LS; Basu R; Christenson M; Hensic L; Paoli C; Wara D; Moskowitz JT
    Pediatrics; 2010 Sep; 126(3):e541-9. PubMed ID: 20696721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world.
    Vijayaraghavan A; Efrusy MB; Mazonson PD; Ebrahim O; Sanne IM; Santas CC
    J Acquir Immune Defic Syndr; 2007 Sep; 46(1):91-100. PubMed ID: 17621241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.
    Enns B; Min JE; Panagiotoglou D; Montaner JSG; Nosyk B;
    BMC Health Serv Res; 2019 Sep; 19(1):626. PubMed ID: 31481056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of late presentation to care and advanced HIV in newly HIV diagnosed subjects in the Republic of Panama: 2012-2017.
    Robles MA; Ortiz AY; Zaldivar Y; Castillo J; Gondola J; Mewa JC; Moreno A; Burgos R; Chavarria O; Castillero O; Gonzalez C; Pascale JM; Martínez AA
    Int J STD AIDS; 2020 Jul; 31(8):791-799. PubMed ID: 32487001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.